No Picture
Trading Ideas

INSIGHT-US-based chip-tech group moving to Switzerland over trade curb fears

* Ex-trade official sees more technology flight from the U.S. SAN FRANCISCO/WASHINGTON, Nov 25 (Reuters) – A U.S.-based foundation overseeing promising semiconductor technology developed with Pentagon support will soon move to Switzerland after several of the group’s foreign members raised concerns about potential U.S. trade curbs. The nonprofit RISC-V Foundation (pronounced risk-five) wants to ensure that universities, governments and companies outside the United States can help develop its open-source technology, its Chief Executive Calista Redmond said in an interview with Reuters. …read more […]

No Picture
Trading Ideas

Malaysia's Khazanah sells stakes worth $1.4 billion, including in Alibaba

Malaysia’s sovereign wealth fund Khazanah Nasional Bhd has sold stakes worth 5.66 billion ringgit ($1.36 billion) in seven foreign firms including Alibaba Group Holding Ltd in the first 16 months of the current government, a minister said. Khazanah [KHAZA.UL], which made its first loss in a decade last year, has been under pressure to raise funds for the debt-laden government of Prime Minister Mahathir Mohamad who took office in May last year. The fund has sold an undisclosed portion of its stake in Chinese e-commerce giant Alibaba worth 2.23 billion ringgit. …read more […]

No Picture
Trading Ideas

Uber Loses London License Over Concerns for Rider Safety

(Bloomberg) — Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.London’s transit authority refused to grant Uber Technologies Inc. a new license in the capital, endangering the ride-hailing company’s future operations in the city.While the company has made some progress in addressing Transport for London’s concerns, the regulator is still concerned that unauthorized drivers can manipulate the app to carry passengers, it said in a statement Monday. Uber has 21 days to appeal and can continue to operate while a magistrates’ court considers the decision.TfL is particularly concerned about a vulnerability in …read more […]

No Picture
Trading Ideas

Uber stripped of London operating licence, again

Uber was stripped of its London operating licence on Monday for the second time in just over two years as the city’s regulator said the taxi app was not “fit and proper”, having put passenger safety at risk. A change to Uber’s systems allowed unauthorised drivers to upload their photos to other drivers’ accounts, meaning they could pick up passengers as if they were the booked driver, which happened in at least 14,000 trips, Transport for London (TfL) said. “It is unacceptable that Uber has allowed passengers to get into minicabs with drivers who are potentially unlicensed and …read more […]

No Picture
Trading Ideas

Roche eyes quick FDA approval in SMA race with Biogen, Novartis

Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. The U.S. Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder. Roche, whose drug is seen as a rival for Biogen’s Spinraza and Novartis’s Zolgensma gene therapy, said the FDA is due to decide by May 24. …read more […]

No Picture
Trading Ideas

Japan's Mitsubishi beats Shell to buy Dutch power firm Eneco

A group led by Japan’s Mitsubishi Corp will buy Eneco in a deal valuing the Dutch energy firm at 4.1 billion euros ($4.52 billion), Eneco said on Monday, beating off rival bidders including Shell and private equity firm KKR. Eneco, a company owned by 44 Dutch municipalities and with a strong focus on renewable energy, said it had been swayed by Mitsubishi’s plans to allow the company to continue its strategy and retain its corporate identity. The deal, backed by Eneco’s boards and a committee representing shareholders, must still be approved early next year by the Dutch company’s …read more […]

No Picture
Trading Ideas

Uber's London licence hangs in the balance on expiry day

London’s transport regulator said on Monday it has yet to decide on whether to renew Uber’s operating licence in the city after a media report said the taxi app would lose its right to take rides in Britain’s capital. LBC radio reported on Monday, the day the Silicon Valley firm’s licence expires in London, that Uber will not receive a new licence in one of its most important markets, citing several unnamed sources. A spokesman at Transport for London (TfL) said no decision has been made. …read more […]

No Picture
Trading Ideas

Uber's London license hangs in the balance on expiry day

London’s transport regulator said on Monday it has yet to decide on whether to renew Uber’s operating license in the city after a media report said the taxi app would lose its right to take rides in Britain’s capital. LBC radio reported on Monday, the day the Silicon Valley firm’s license expires in London, that Uber will not receive a new license in one of its most important markets, citing several unnamed sources. A spokesman Transport for London said no decision has been made. …read more […]

No Picture
Trading Ideas

China's electric vehicle market to see sales rebound next year, executives say

GUANGZHOU, China/Shanghai (Reuters) – China’s new energy vehicle (NEV) market is likely to see a sales rebound next year as automakers roll out more new products to lure buyers, but more supportive government policies are needed, auto executives said. China has been a keen supporter of NEVs and has implemented production quota requirements for automakers. In October, NEV sales fell 45.6% from year-ago levels. …read more […]

No Picture
Trading Ideas

UPDATE 1-Roche eyes quick FDA approval in SMA race with Biogen, Novartis

Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. The U.S. Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder. Roche, whose drug is seen as a rival for Biogen’s Spinraza and Novartis’s Zolgensma gene therapy, said the FDA is due to decide by May 24. …read more […]

No Picture
Trading Ideas

European shares lifted by U.S.-China trade optimism; LVMH gains

European shares rose for the second straight session on Monday following reports that Washington and Beijing were nearing a trade agreement, while LVMH gained after signing a deal to buy U.S. jewellery chain Tiffany. A Chinese state-backed tabloid said on Monday China and the United States were “very close” to an initial trade agreement, adding to optimism from Friday, when the presidents of both the countries reiterated their desire for a deal. The pan-European STOXX 600 index was up 0.6% at 0802 GMT, led by trade-sensitive miners. …read more […]

No Picture
Trading Ideas

Istanbul Working on Eurobonds After State Banks ‘Shut the Doors’

(Bloomberg) — Istanbul is working on a plan to sell Eurobonds to finance projects after state lenders “shut the doors” on the city’s opposition-run local government, according to Mayor Ekrem Imamoglu.“It’s sad that the state lenders remain distant to us since we came into office,” Imamoglu told reporters on Sunday. “I don’t know what their motives are. However, I have no doubt that we will find funding from Europe.”The new mayor’s remarks highlight the difficulties he faces running the nation’s largest city after wresting control from Presidetn Recep Tayyip Erdogan’s ruling AK Party. Imamoglu was in London earlier this month …read more […]